Royal Mail PLC

Deutsche Bank cuts Royal Mail target price as it warns dividend is “unsustainable”

It is not just Deutsche Bank which thinks Royal Mail will be forced to cut its dividend soon; others, including Liberum, have echoed those concerns of late

royal mail worker
Deutsche thinks Royal Mail shares are worth just 180p – 100p below where they currently sit

Deutsche Bank has once again reiterated its belief that Royal Mail PLC’s (LON:RMG) current dividend is “unsustainable” and should be cut.

In last week’s third-quarter results, the postal giant cut the upper range of its 2019 profit forecast on expectations that letter volumes will decline more than previously estimated, while parcel deliveries will slow, too.

READ: Deutsche Bank cuts Royal Mail target price

With a rebound in profit or cash flow looking unlikely any time soon, Deutsche Bank warned again that the dividend is now facing the chop as it cut its own divi predictions.

“We cut our 2019/20E dividend using what we think is a more sustainable dividend pay-out ratio of 70% of earnings,” read a note to clients.

Analysts at the German investment bank also chopped the price target to 180p from 250p – implying a 35% downside from the current market price of 278.2p.

Liberum looking for a cut, too

Deutsche Bank isn’t the only one tipping a dividend cut; City broker Liberum said in a note last week that it, too, is expecting one.

“The annual cash cost of more than £240m could go a long way to funding a restructuring programme,” said Liberum.

“We think it is unlikely that the dividend will be suspended altogether, although that cannot be ruled out.”

Quick facts: Royal Mail PLC

Price: £2.25

Market: LSE
Market Cap: £2.25 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

21 hours, 3 minutes ago


Directorate Change

1 day, 7 hours ago

Holding(s) in Company

2 days, 3 hours ago

Director/PDMR Shareholding

3 days, 2 hours ago

Director/PDMR Shareholding

1 week, 3 days ago

Director/PDMR Shareholding

1 week, 4 days ago

Holding(s) in Company

2 weeks, 1 day ago

2 min read